ESC 2023 kardiomiyopatiya yo'riqnomalari: asosiy yangilanishlar va amaliyotga tatbiq etish
Annotatsiya
Kirish. 2023-yilgi ESC kardiomiyopatiya yo'riqnomalari tashxis qo'yish mezonlari, atamalar va davolash protokollarida muhim yangilanishlarni kiritdi. Ushbu yo'riqnomalar tashxis va davolash bo'yicha kompleks yondashuvlarni taqdim etishni maqsad qilgan.
Materiallar va metodlar. 2023-yilgi ESC yo'riqnomalari va tegishli adabiyotlar o'rganilib, tashxis yondashuvlari va davolash standartlaridagi o'zgarishlar keltirildi.
Natijalar. ESC 2023 yo'riqnomalari kardiomiyopatiyalar uchun qayta ko'rib chiqilgan tashxis mezonlarini, masalan, dilatatsiyalanmagan chap qorincha kardiomiyopatiyasini (NDLVC) o'z ichiga olgan yangi atamalarni kiritdi va davolashning yangilangan tavsiyalarini taklif etdi, bunda shaxsiylashtirilgan yondashuvlar va genetika nuqtai nazaridan ahamiyatga ega.
Xulosa. ESC 2023 yo'riqnomalari kardiomiyopatiyalarning tashxisi va davolashini yaxshilashga yordam beruvchi muhim yangilanishlarni taqdim etadi va klinik amaliyotlarda takomillashtirilgan yondashuvlarni rag'batlantiradi.
Kalit so‘zlar:
Mualliflar haqida
Adabiyotlar ro'yxati
Arbelo E., Protonotarios A., Gimeno J.R., 2023 ESC Guidelines for the management of cardiomyopathies, Eur Heart J, 2023, 44, 037, 3503–3626, 10.1093/eurheartj/ehad194.
Goodwin J.F., Gordon H., Hollman A., Bishop M.B., Clinical aspects of cardiomyopathy, Br Med J, 1961, 1, 69–79, 10.1136/bmj.1.5219.69.
Pinto Y.M., Elliott P.M., Arbustini E., Proposal for a revised definition of dilated cardiomyopathy, Eur Heart J, 2016, 37, 023, 1850–1858, 10.1093/eurheartj/ehv727.
Hershberger R.E., Hedges D.J., Morales A., Dilated cardiomyopathy: the complexity of a diverse genetic architecture, Nat Rev Cardiol, 2013, 10, 09, 531–547, 10.1038/nrcardio.2013.105.
Lund L.H., Edwards L.B., Dipchand A.I., The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Heart Transplantation Report-2016, J Heart Lung Transplant, 2016, 35, 010, 1158–1169, 10.1016/j.healun.2016.08.017.
Halliday B.P., Gulati A., Ali A., Sex- and age-based differences in the natural history of dilated cardiomyopathy, Eur J Heart Fail, 2018, 20, 010, 1392–1400, 10.1002/ejhf.1216.
Schultheiss H.P., Fairweather D., Caforio A.L.P., Dilated cardiomyopathy, Nat Rev Dis Primers, 2019, 5, 01, 32, 10.1038/s41572-019-0084-1.
Ferreira A., Ferreira V., Antunes M.M., Comprehensive approach to diagnosis and risk stratification in dilated cardiomyopathy, Biomedicines, 2023, 11, 03, 834, 10.3390/biomedicines11030834.
Donal E., Delgado V., Bucciarelli C.Ducci., Multimodality imaging in the diagnosis of dilated cardiomyopathies, Eur Heart J Cardiovasc Imaging, 2019, 20, 010, 1075–1093, 10.1093/ehjci/jez178.
McDonagh T.A., Metra M., Adamo M., 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, Eur Heart J, 2021, 42, 3599–3726, 10.1093/eurheartj/ehab368.
Ferro M.D., Stolfo,D., Altinier A., Association between mutation status and left ventricular reverse remodeling in dilated cardiomyopathy, Heart, 2017, 103, 1704–1710, 10.1136/heartjnl-2016-311017.
Oghina S., Bougouin W., Bezard M., The impact of cardiac amyloidosis in HFpEF trials, JACC Heart Fail, 2021, 9, 169–178, 10.1016/j.jchf.2020.12.005.
Halliday B.P., Wassall R., Lota A.S., Withdrawal of pharmacological treatment in recovered dilated cardiomyopathy, Lancet, 2019, 393, 61–73, 10.1016/S0140-6736(18)32484-X.
Arbustini E., Narula N., Tavazzi L., The MOGE(S) classification of cardiomyopathy for clinicians, J Am Coll Cardiol, 2014, 64, 03, 304–318, 10.1016/j.jacc.2014.05.027.
Ahmad F., Seidman J.G., Seidman C.E., The genetic basis for cardiac remodeling, Annu Rev Genomics Hum Genet, 2005, 6, 185–216, 10.1146/annurev.genom.6.080604.162132.
Orphanou N., Papatheodorou E., Anastasakis A., Dilated cardiomyopathy in the era of precision medicine, Heart Fail Rev, 2022, 27, 04, 1173–1191, 10.1007/s10741-021-10139-0.
de Boer R.A., Heymans S., Backs J., Targeted therapies in genetic dilated and hypertrophic cardiomyopathies, Eur J Heart Fail, 2022, 24, 406–420, 10.1002/ejhf.2447.
Arbelo E., Gimeno J.R., Narula J., The role of imaging in the diagnosis of cardiomyopathies, Eur Heart J, 2023, 44, 09, 885–901, 10.1093/eurheartj/ehad085.
Pinto Y.M., Elliott P.M., Arbustini E., Revised criteria for diagnosis of cardiomyopathies, Eur J Heart Fail, 2017, 19, 03, 307–315, 10.1002/ejhf.822.
Hershberger R.E., Givertz M.M., Ho C.Y., Genetic testing in cardiomyopathy: key insights, Nat Rev Cardiol, 2020, 17, 08, 457–470, 10.1038/s41569-020-0372-2.
Copyright (c) 2024 Абдуллаев Т.А. , Цой И.А. (Автор)
Ushbu asar saytida mavjud litsenziyalar Creative Commons «Attribution-NonCommercial-ShareAlike» («Atribut - notijorat maqsadlarda foydalanish - bir xil shartlar») 4.0 Всемирная.